Articles tagged with Cancer Medication
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
Researchers successfully reduced metastatic spread by using medication treatment around the time of surgery, preventing development of metastases. The study found a significant reduction in metastasis development rate in treated patients compared to those receiving a placebo.
A new study uses patient-specific tumor organoids to identify the most effective chemotherapy protocol for treating advanced stages of colon and appendiceal cancer. The approach shows promise in tailoring treatment to individual patients, potentially increasing life expectancy.
Researchers efficiently synthesized cepafungin I, a natural compound with promise as an anti-cancer agent, using a lean new process that overcame its complex molecular structure. The compound targets the proteasome, a strategy used by many existing cancer medications.
A new study by Vanderbilt University Medical Center researchers finds that Medicare Part D plans favor generic drugs over brand-name counterparts, with only 0.9% of plans covering only the brand name in 2019. Generic drugs were often on the same or lower cost-sharing tier as brand names, saving patients out-of-pocket costs.
Researchers at GW Cancer Center demonstrate that HDAC6 inhibitors can both enhance immunotherapy's effectiveness and decrease breast cancer's invasiveness, offering new treatment options for triple-negative breast cancer patients.
Disulfiram, used to treat alcoholism, has shown potential against SARS-CoV-2 by inhibiting viral replication and reducing glutathione levels, while neratinib, an experimental breast cancer treatment, also demonstrates effectiveness in blocking coronavirus protease M pro.
Researchers at Ohio State University Comprehensive Cancer Center have found that molecular characteristics can refine prognostic recommendations for AML patients under age 60. The study detected mutations in several categories, which were associated with better or worse outcomes and may help improve treatment choices.
Researchers at Sanford Burnham Prebys Medical Discovery Institute have discovered a novel drug target, PPP1R1B, that stops the spread of pancreatic cancer in mice. Increased levels of this protein have been found in tumor samples from people with metastatic pancreatic cancer, suggesting it has therapeutic potential.
Researchers at Huntsman Cancer Institute develop new models to study molecular characteristics of lung and pancreas tumors driven by NTRK1 mutations. The findings aim to identify effective treatments for patients with NTRK1-driven cancers, which have proven resistant to current therapies.
Researchers studying cichlid fishes aim to understand genetic mechanisms controlling facial development, which may also apply to humans. The study's findings could help determine if certain medications prescribed for human diseases might cause facial malformations in unborn babies.
A blood test can predict which cancer patients will benefit from immunotherapy, a treatment option for advanced cancers. The test analyzes changing levels of tumour fragments in the blood to identify those who will respond well to the treatment.
Researchers at CeMM developed a scalable strategy to discover novel molecular glue degraders, which can eliminate disease-causing proteins by targeting the cellular protein quality control system. The study identifies a set of novel compounds that induce the degradation of cyclin K, essential in many cancer types.
A new study from UC San Diego researchers reveals that an investigational drug candidate called tipifarnib shows promise in treating head and neck cancer tumors with mutations in the HRAS gene. The findings support the idea that HRAS represents a druggable oncogene in HNSCC, providing a precision therapeutic option.
Dr. Britta Will, an assistant professor at Albert Einstein College of Medicine, has won the prestigious Pershing Square Sohn Prize for her innovative cancer research. Her studies focus on understanding mechanisms that create and sustain cancer stem cells in acute myeloid leukemia and myelodysplastic syndrome.
Researchers found that combining pan-Bcl-2 inhibitors with cancer treatments can cause healthy cells to die, leading to reproductive and developmental defects. The study highlights the need for awareness about adverse effects of certain drugs like navitoclax.
Researchers identified phosphoprotein biomarkers to guide cancer therapy, demonstrating a novel approach for identifying and detecting tumor drivers. The study's findings suggest that precision medicine is a realizable goal for rare and recalcitrant cancers.
A deep learning algorithm can quickly and accurately screen cancer patient biopsies for genetic alterations that inform treatment options and likelihood to respond to specific therapies. The study found detectable mutations in 13 out of 14 tested tumor types, including lung, colorectal, breast, and gastric cancers.
Researchers found that patients treated with radioactive iodine and surgery for hyperthyroidism have a higher risk of dying from solid cancer compared to those treated with anti-thyroid drugs. The study suggests that the long-term effects of these treatments on cancer mortality rates are significant.
Physician-scientists use a comprehensive genomic analysis tool to determine the best treatment plan for each individual patient. The study suggests that mutations in the TERT gene can predict a patient's response to immune checkpoint inhibitors.
Newly released CCC19 data show a racial disparity in access to Remdesivir, an antiviral drug that shortens hospital stays, and increased mortality associated with dexamethasone, a steroid. Black patients were half as likely to receive Remdesivir as white patients.
Researchers found that some mutations actually generate 'noise' that can counteract cancer development, leading to a dead end. New drug combinations aim to reactivate suppressed pathways to disrupt oncogenic signal transduction in cancer cells.
Researchers have demonstrated the potential of a leukemia drug, arsenic trioxide, to treat medulloblastoma, a type of brain cancer most common in children. The drug made tumor cells more sensitive to radiation therapy and proved capable of killing tumor cells and preventing new colony formation.
Scientists have tracked quadruple helix DNA formation in living human cells for the first time, allowing them to see how it works and its possible role in cancer. The discovery could reveal new targets for drugs that interrupt gene expression, a fundamental process in gene regulation.
Scientists have discovered a potential new target for treating Ewing sarcoma, a childhood cancer that affects the bone and soft tissue. The researchers found that an imbalance in genetic code-reading machines causes nucleoli to break up into smaller entities in Ewing sarcoma.
Researchers discovered that a protein called Neuropilin-1 (NRP1) suppresses immune responses to cancer. Blocking NRP1 improves the immune system's ability to remember tumors, leading to better protection against recurrence and improved response to immunotherapy.
Researchers at Uppsala University have discovered new ways to combine drugs for glioblastoma patients, tailoring therapy to individual tumours. The study characterised how genetic aberrations influence drug effectiveness, revealing two main subgroups based on response and mutations.
Moffitt researchers found that umbralisib, a PI3K/CK1ε inhibitor, showed fewer immune-mediated side effects compared to traditional PI3K inhibitors. The study suggests that dual inhibition may improve safety profiles for CLL patients.
Researchers found that arsenic trioxide can restore the body's natural antiviral factories to fight adenovirus infections. The medication has been approved for leukemia treatment and shows promise in inhibiting adenovirus replication without developing resistance.
Peter S. Conti, MD, PhD, received the 2020 Benedict Cassen Prize for his pioneering work in radiopharmaceuticals and clinical PET applications for cancer imaging. The award recognizes his contributions to advancing nuclear medicine and molecular imaging.
A study by TGen has identified a drug, SP-2577, which can enable the immune system to attack ovarian cancer. The drug, also known as Seclidemstat, was developed to inhibit LSD1, a protein that is abundant in SCCOHT ovarian cancer.
A ground-breaking clinical trial is underway at Sheba Medical Center in Israel to evaluate the Immunicom LW-02 plasma filtration device as a monotherapy and in combination with an anti-PD-1 immune checkpoint inhibitor. The trial aims to treat resistant metastatic melanoma, triple-negative breast cancer, renal cell carcinoma, and non-sm...
A recent study analyzing 10 years of HPV-vaccine related Facebook posts reveals that anti-vaxxers have gained a stronger voice against the use of the human papillomavirus vaccine. Negative posts displayed a 45% increase in public engagement, with some showing negative views on vaccine safety and effectiveness.
A large study found that taking common hypertension medications such as ACE inhibitors and ARBs can lower the risk of developing colorectal cancer. The benefits were seen in patients over 55 and those with a history of colon polyps, but only for the first three years after a negative baseline colonoscopy.
A study published in CANCER found that Medicaid expansion significantly reduced the likelihood of being diagnosed with deadly metastatic cancer among Americans with low income. The research analyzed data from 12,760 individuals and showed a 15% lower odds of having metastatic cancer after Medicaid expansion.
Brooke Emerling receives a four-year grant to study targeting tumors with p53 gene mutations, which are present in most human cancers. Her research aims to develop new approaches to eliminating cancer as a major health problem.
Researchers found that a low-dose combination of four inhibitors is more effective in treating NSCLC with EGFR mutation. The therapy, called MLD, inhibits the action of multiple proteins in the same signaling pathway, blocking cell proliferation and tumor growth.
Researchers found that olaparib depletes the store of immature eggs in mouse ovaries by 36%, potentially affecting a woman's fertility. Fertility preservation counselling should be considered for young female patients prior to olaparib treatment.
Researchers found that a single change in the GRP94 protein causes it to behave abnormally, leading to widespread dysfunction in cells. A new small molecule PU-WS13 has been identified as a potential treatment for cancer and Alzheimer's disease by repairing defects in the defective protein.
Researchers have discovered a novel protein, death-associated protein 3 (DAP3), that drives the growth of cancers by altering genetic code. DAP3 inhibits RNA editing, which normally corrects genetic errors, acting as an oncogene and promoting cancer development.
A Yale Cancer Center study confirms the effectiveness of combining chemotherapy and trastuzumab in treating aggressive uterine serous carcinoma, a rare form of endometrial cancer. The treatment significantly improves progression-free survival, with no increase in toxicity.
A new study suggests that a type of MRI scan used for heart disease can also pick out aggressive cancers in children. The T1-mapping technique measures how water molecules interact inside cells, allowing clinicians to understand the cellular make-up of tissue and spot early signs of treatment effectiveness.
Russian scientists have discovered four new steroid substances extracted from starfish that target human breast cancer and colorectal carcinoma cells. These non-typical derivatives of polar steroids may also help nerve cells survive distress, suggesting potential applications in Alzheimer's disease prevention.
A new study has identified a key signaling pathway in the development of Paget's disease, a rare and debilitating skin cancer. Researchers found that using a topical cream containing an FDA-approved drug can alleviate clinical symptoms in patients with Paget's disease.
A new study reveals that the enzyme SAMHD1 protects B-ALL cells from nelarabine's anti-cancer effects, but not T-ALL cells. This discovery has crucial implications for leukaemia treatment, offering a potential biomarker to tailor therapy to individual patient needs.
A new study from Memorial Sloan Kettering Cancer Center finds that increased activity of the normal metabolic enzyme SHMT2 transforms normal B cells into B cell lymphomas. The enzyme binds to tumor suppressor proteins, turning them off and resulting in the development of lymphoma.
A new study finds that chemicals can cause changes in cells to evade the immune system and build resistance to cancer drugs. The team identified specific combinations of mutations that create cancer cells, which could aid doctors in prescribing the most appropriate course of chemotherapy.
Researchers at Goethe University Frankfurt and University of Kent have discovered that the enzyme SAMHD1 can split phosphate groups off nelarabine, making it less effective in B-ALL patients. This breakthrough could lead to more targeted treatment options for individual patients.
A new study finds that high deductible health plans are widening the racial health gap among black and white cancer survivors. Black cancer survivors on these plans face significant cost-related barriers to care, including skipping medication or delaying refills.
A study by Queen Mary University of London uncovers novel pathways controlling cancer progression, identifying Rac1 as a critical player in MET-driven processes. The findings may pave the way for more efficacious treatment regimens by targeting MET, PI3K, and mTOR.
Researchers at UC San Diego School of Medicine discovered a new way to treat cancer by manipulating macrophages, immune cells found in tumor tissues. IRE1α, a molecule regulating the unfolded protein response, was shown to boost PD-L1 levels on macrophages, allowing tumors to evade the immune system.
A recent study by SWOG Cancer Research Network found that black cancer patients are more likely to be enrolled in taxpayer-funded clinical trials compared to industry-sponsored trials. The study analyzed data from over 93,000 patients across 358 trials and found a significant disparity in representation.
Scientists at City of Hope and TGen found that circulating immune cell dynamics can inform how patients respond to immunotherapy. The study's findings highlight an important predator-prey relationship between immune cells and tumor response.
A large retrospective cohort study found that flu vaccination was associated with a small increased risk for subdeltoid bursitis. Researchers suggest education and training on proper injection technique could prevent this adverse event.
A new class of precision medicine targeting cancer's ability to repair its DNA has shown promising results, with half of patients experiencing tumor growth halt. The drug works by stopping cancers from repairing DNA damage and is particularly effective when combined with chemotherapy.
Researchers at the University of South Australia have developed a novel formulation of the prostate cancer drug abiraterone acetate, improving its effectiveness by 40%. The new oral formulation reduces side effects and allows for a smaller dose to be effective without fasting.
KinaRx aims to create more effective drugs using a novel platform that targets gene mutations driving cancer growth. The company has developed novel RET inhibitors with promising results in preclinical experiments.
Researchers have found that certain cancer therapeutics concentrate within cells' tiny functional compartments called organelles, known as condensates. This discovery could lead to a new toolset for drug development by tailoring chemicals to seek out and concentrate in specific droplets.
A 84-year-old woman with breast cancer and controlled hypertension developed a life-threatening arrhythmia after chloroquine treatment, resolving after discontinuation. The case highlights the risks of QT interval prolongation and torsade de pointes in patients treated with chloroquine for COVID-19.
A cancer drug called ruxolitinib was used to treat a COVID-19 patient with acute respiratory distress, resulting in clinical stabilization and rapid improvement in respiration and heart function. The treatment's success has led to the approval of a clinical trial to test its effect on additional COVID-19 patients.
A new study has discovered a direct link between mutations in the p53 tumor suppressor gene and the KRAS oncogene, driving the formation of pancreatic cancer. The research provides insight into the mechanism that regulates cell activity, offering potential therapeutic targets for future development.